Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XP12B (Lysteda) in Menorrhagia
NCT00401193Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Nov 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in Menorrhagia (3 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Mean Reduction From Baseline in Menstrual Blood Loss (MBL). Started Nov 2006; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Menorrhagia
Beyond the preview
Go deeper on NCT00401193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401193.